Form 4 for ABEO ABEONA THERAPEUTICS INC.
Accepted 2023-03-21 00:00:00 ET · period of report 2023-03-20 · accession 0001493152-23-008429 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023-03-21 | 2023-03-20 | ABEO | Amoroso Michael | Dir | S - Sale | $2.33 | -268 | 56.4K | -0.5% | -$624.44 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-03-20 | S | D | 268 | $2.33 | 56,441 | D | — | — | (F1) The sale reported in this Form 4 was to cover tax obligations associated with vesting of restricted stock awards. |